Quantitative measurements of menstrual blood loss in ovulatory and anovulatory cycles in middle- and late-reproductive age and the menopausal transition
- PMID: 20093896
- DOI: 10.1097/AOG.0b013e3181ca4b3a
Quantitative measurements of menstrual blood loss in ovulatory and anovulatory cycles in middle- and late-reproductive age and the menopausal transition
Abstract
Objective: To measure menstrual blood loss before and during the menopausal transition and to explore the relationships between menstrual blood loss and menstrual cycle irregularity and reproductive hormone levels.
Methods: Two consecutive menstrual blood loss measurements were performed in 77 healthy women aged 21-55 years, classified as midreproductive age (n=21, control group), late-reproductive age (n=17), early-menopausal transition (n=16), and late-menopausal transition (n=23). Serum hormone levels (estradiol [E2], progesterone, follicle-stimulating hormone, luteinizing hormone, and inhibins) were measured three times per week from the start of one menstrual period to the end of the subsequent menstrual period.
Results: There were nine, one, zero, and two anovulatory cycles captured in the late-menopausal transition, early-menopausal transition, late-reproductive age, and midreproductive age groups, respectively. The median (range) menstrual blood loss values after ovulatory cycles were 30 (142), 33 (147), 55.7 (105), and 68.9 (234) mL in the midreproductive age, late-reproductive age, early-menopausal transition, and late-menopausal transition groups, respectively. After anovulatory cycles in the late-menopausal transition group, menstrual blood loss was only 11.8 (97) mL. In the late-menopausal transition group, menstrual blood loss after an ovulatory cycle was significantly higher than when occurring after an anovulatory cycle (P=.008, Kruskal-Wallis). The highest menstrual blood loss measurements were in women in the late-menopausal transition group who experienced ovulatory cycles with abnormally high E2 levels and disturbed E2 secretion patterns.
Conclusion: The onset of variability in menstrual blood loss was associated with the onset of irregular cycles. Excessive menstrual blood loss (greater than 250 mL) was associated with ovulatory cycles with high E2 levels and late menopausal transition.
Level of evidence: III.
Similar articles
-
Menstrual Cycle Changes as Women Approach the Final Menses: What Matters?Obstet Gynecol Clin North Am. 2018 Dec;45(4):599-611. doi: 10.1016/j.ogc.2018.07.003. Epub 2018 Oct 25. Obstet Gynecol Clin North Am. 2018. PMID: 30401545 Review.
-
Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.Menopause. 2009 Jan-Feb;16(1):50-9. doi: 10.1097/GME.0b013e31817ee0c2. Menopause. 2009. PMID: 18978637
-
Cycle and hormone changes during perimenopause: the key role of ovarian function.Menopause. 2008 Jul-Aug;15(4 Pt 1):603-12. doi: 10.1097/gme.0b013e318174ea4d. Menopause. 2008. PMID: 18574431
-
Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system.J Clin Endocrinol Metab. 2007 Aug;92(8):3060-7. doi: 10.1210/jc.2007-0066. Epub 2007 Jun 5. J Clin Endocrinol Metab. 2007. PMID: 17550960
-
The menopause: when it is all over or is it?Aust N Z J Obstet Gynaecol. 1994 Jun;34(3):293-5. doi: 10.1111/j.1479-828x.1994.tb01076.x. Aust N Z J Obstet Gynaecol. 1994. PMID: 7848203 Review.
Cited by
-
Clomiphene citrate plus letrozole versus clomiphene citrate alone for ovulation induction in infertile women with ovulatory dysfunction: a randomized controlled trial.BMC Womens Health. 2023 Nov 14;23(1):602. doi: 10.1186/s12905-023-02773-7. BMC Womens Health. 2023. PMID: 37964246 Free PMC article. Clinical Trial.
-
Endometrial polyps.Rom J Morphol Embryol. 2022 Apr-Jun;63(2):323-334. doi: 10.47162/RJME.63.2.04. Rom J Morphol Embryol. 2022. PMID: 36374138 Free PMC article.
-
Transitioning to the menopausal transition: a scoping review of research on the late reproductive stage in reproductive aging.Menopause. 2021 Jan 15;28(4):447-466. doi: 10.1097/GME.0000000000001707. Menopause. 2021. PMID: 33470754 Free PMC article. Review.
-
Prevention of unintended pregnancy and use of contraception-important factors for preconception care.Ups J Med Sci. 2016 Nov;121(4):252-255. doi: 10.1080/03009734.2016.1208310. Epub 2016 Sep 20. Ups J Med Sci. 2016. PMID: 27646655 Free PMC article.
-
Recent advances in managing and understanding menstrual disorders.F1000Prime Rep. 2015 Mar 3;7:33. doi: 10.12703/P7-33. eCollection 2015. F1000Prime Rep. 2015. PMID: 25926984 Free PMC article. Review.
References
-
- Kaufert PA. The perimenopausal woman and her use of health services. Maturitas 1980;2:191–205.
-
- Mitchell ES, Woods NF. Symptom experiences of midlife women: observations from the Seattle Midlife Women’s Health Study. Maturitas 1996;25:1–10.
-
- Ballinger CB, Browning MC, Smith AH. Hormone profiles and psychological symptoms in peri-menopausal women. Maturitas 1987;9:235–51.
-
- Fraser IS. Menstrual changes during the perimenopause. In: Lobo RA, editor. The Perimenopause. Proceedings of an International Serono USA Symposium on the Perimenopause. New York (NY): Springer-Verlag; 1997. p. 233–45.
-
- Brown JB, Kellar R, Matthew GD. Preliminary observations on urinary oestrogen excretion in certain gynaecological disorders. J Obstet Gynaecol Br Emp 1959;66:177–211.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials